 France24 |
FDA Wants More Answers About MS Drug From Merck
Medical News Today The Food and Drug Administration has really been buckling down this year, and rightfully so, demanding more evidence of success and deeper understanding of potential safety risks of new manufactured medications. Merck KGaA in Germany is no different, … Merck KGaA Fails To Get FDA OK For Cladribine Pill Novartis MS pill gets boost from Merck rejection FDA Turns Down Cladribine for MS |
View full post on Health – Google News
